ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation

Genfleet Therapeutics (Shanghai) Inc. · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
pancreatic-ductal-adenocarcinoma
advanced solid tumors cancer, pancreatic ductal adenocarcinoma, ras mutation, gfh276, pdac, solid tumors, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 882960
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.